AzTrials
AzTrials

VaricocelePhase 4NCT01463787

Comparison of Outcomes of Two Approaches in Microsurgical Varicocelectomy in Chinese Infertile Males: A Prospective Randomized, Controlled Trial

A Phase 4 study testing microsurgical varicocelectomy in inguinal approach and microsurgical varicocelectomy in subinguinal approach in people with Varicocele, run by Feng Pan at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Varicocele is the most common surgical disease which could lead to male infertility. It is found in approximately 15% adult males, and in about 40% infertile males. And the incidence is up to 80% in secondary infertility. Read more about this study

Who is it for?
Ages 20 to 46 years, men only
Conditions the study is for
Varicocele
What is being tested?
microsurgical varicocelectomy in inguinal approach and microsurgical varicocelectomy in subinguinal approach
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteChina
Study dates
Jan 2009to Dec 2010
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 46 years
  • Men only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Primary infertility (more than 1 year)
  • Serum hormone was normal (FSH, LH, T and PRL)
  • Semen analysis which was taken within 3-7 days of abstinence was abnormal for at least twice, and at least 1 month apart (the value of sperm density was less than 20 million per ml, and/or sperm motility a+b was less than 50%, according to the 4th WHO criteria)
  • All varicocele was diagnosed by physical examination and testified by color Doppler ultrasound
  • Patients' spouse was healthy in reproduction or had some curable generational diseases

Who cannot join

  • Secondary infertility
  • Men with subclinical varicocele or normal semen analyses
  • Having some other surgical diseases, such as genital tract infection or deformity
  • Having some congenital diseases, such as Klinefelter and Y chromosome deficiency
  • Having some endocrine diseases, such as Kallmann, abnormality in pituitary gland, hyperthyroidism, hypercorticoidism, and so on
  • Patients' spouse had some diseases that made them unable to carry out spontaneous pregnancy, such as tubal obstruction or ovulatory failure.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Nanjing Maternity and Child Healthcare Hospital Affiliated to Nanjing Medical University

    Nanjing, Jiangsu, 210004

Other trials in China

About this study

Varicocele is the most common surgical disease which could lead to male infertility. It is found in approximately 15% adult males, and in about 40% infertile males. And the incidence is up to 80% in secondary infertility. In the past, there was continuous controversy over whether a varicocele repair could improve fertility. But at present, researches are coming to a consensus on the indication of varicocelectomy. Several researches manifest that the microsurgery of varicocele could have the effect of the highest spontaneous pregnancy and lowest complications rate after surgery. Microsurgical varicocelectomy includes two approaches, inguinal and subinguinal. Each one has its advantages and disadvantages. There are few studies which make direct comparison between the two methods in microsurgical varicocelectomy, especially in China. Operators have made decisions on the basis of their own experience and skills. In this study, the investigators compare the postoperative spontaneous pregnancy and complications rates in two approaches in microsurgical varicocelectomy for Chinese infertile men in their hospital.

Read the detailed description

Outcome Measures

Before surgery, all patients were diagnosed by physical examination and testified by color Doppler ultrasound. And one trained nurse documented the patients' age, left unilateral or bilateral and the grade of varicocele, and the grade of the more serious side was noted when handled with bilateral ones. During surgery, the duration of surgery was documented. After surgery, a Visual Analogue Scale (VAS) was used to assess the introperative pain after anesthesia recovery and the amount of postoperative pain one month postoperatively by another trained nurse. And the patients whose pain scores > 3 and/or who claimed pain were prescribed with ibuprofen sustained-release capsules (China SmithKline Pharmaceutical Company, Tianjing, China) (0.3g) (ISRC) every 12h on the surgical day (since 2h postoperatively) and only if necessary on the following days (no patient claimed that he had gastrointestinal ulcer history or allergic history of relative drug). Parents were told to write down on a provided form how many times they gave medicine postoperatively. Patients were followed with visits 1 month, 3, 6 and 12 months after surgery, and were encouraged to visit the clinic anytime when they had any complaint in this period. The semen analyses were conducted in the 3, 6 and 12 months in the follow-up. The recurrence or hydrocele formation was testified by color Doppler ultrasound (with/without detected by physical examination) by the same doctor who did the preoperative examination. And this doctor and two nurses mentioned above were all unaware of the patients' groups.

Conditions
Varicocele
Being tested
microsurgical varicocelectomy in inguinal approach, microsurgical varicocelectomy in subinguinal approach
Keywords
Infertility, varicocelectomy, microsurgery, Chinese men, pregnancy rate
Medical subject headings
Varicocele, Infertility

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • microsurgical varicocelectomy in inguinal approachProcedure or surgery

    In inguinal approach, the incision, which was about 3cm, was made two fingers up the pubic symphysis, from external inguinal rings parallel to the inguinal ligament.

  • microsurgical varicocelectomy in subinguinal approachProcedure or surgery

    In subinguinal approach, the incision was about 3 cm horizontal and 1 cm below the external inguinal ring.

Study groups in NCT01463787
Study groupRoleWhat they receive
inguinal groupExperimentalNot described
Receives: Procedure: microsurgical varicocelectomy in inguinal approach
sub-inguinal groupActive comparatorNot described
Receives: Procedure: microsurgical varicocelectomy in subinguinal approach

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pregnancy

    Postoperative spontaneous pregnancy is considered to be the best indicator to assess fertility status.

    Measured: within the 12-24 months postoperative period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Nov 2011 (estimated)
  2. Study startJan 2009
  3. Primary completionDec 2010
  4. Study completionDec 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01463787
Sponsor's protocol ID
FPan
Status last verified
Apr 2013
First submitted
26 Oct 2011
Last updated
10 Apr 2013
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing microsurgical varicocelectomy in inguinal approach and microsurgical varicocelectomy in subinguinal approach in people with Varicocele, run by Feng Pan at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Apr 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pregnancy (time frame: within the 12-24 months postoperative period). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Apr 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in